Li Y, Gan X, Liang Z, Ye H, Lin Y, Liu Q
BMC Womens Health. 2023; 23(1):238.
PMID: 37158842
PMC: 10165758.
DOI: 10.1186/s12905-023-02383-3.
Choi Y, Lichterman J, Coughlin L, Poulides N, Li W, Del Valle P
Sci Immunol. 2023; 8(81):eabo2003.
PMID: 36867675
PMC: 10080670.
DOI: 10.1126/sciimmunol.abo2003.
Murugan D, Murugesan V, Panchapakesan B, Rangasamy L
Cancers (Basel). 2022; 14(21).
PMID: 36358857
PMC: 9653801.
DOI: 10.3390/cancers14215438.
Giurini E, Madonna M, Zloza A, Gupta K
Cancers (Basel). 2022; 14(12).
PMID: 35740589
PMC: 9221178.
DOI: 10.3390/cancers14122923.
Hu C, Chang Y, Liu C, Yu Y, Mou K
Mol Ther. 2022; 30(7):2522-2536.
PMID: 35440418
PMC: 9263318.
DOI: 10.1016/j.ymthe.2022.04.008.
TLR2 and TLR4 Signaling Pathways and Gastric Cancer: Insights from Transcriptomics and Sample Validation.
Zargari S, Bahari A, Goodarzi M, Mahmoodi M, Valadan R
Iran Biomed J. 2021; 26(1):36-43.
PMID: 34773930
PMC: 8784901.
DOI: 10.52547/ibj.26.1.36.
Multifactorial causation of early onset colorectal cancer.
Lazarova D, Bordonaro M
J Cancer. 2021; 12(22):6825-6834.
PMID: 34659571
PMC: 8517991.
DOI: 10.7150/jca.63676.
Effects of infections on the pathogenesis of cancer.
Liardo R, Borzi A, Spatola C, Martino B, Privitera G, Basile F
Indian J Med Res. 2021; 153(4):431-445.
PMID: 34380789
PMC: 8354054.
DOI: 10.4103/ijmr.IJMR_339_19.
A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8 T cell-mediated anti-tumor immunity.
Watkins-Schulz R, Tiet P, Gallovic M, Junkins R, Batty C, Bachelder E
Biomaterials. 2019; 205:94-105.
PMID: 30909112
PMC: 6594365.
DOI: 10.1016/j.biomaterials.2019.03.011.
Spontaneous Regression of Ovarian Carcinoma After Septic Peritonitis; A Unique Case Report.
Roelofsen T, Wefers C, Gorris M, Textor J, Massuger L, de Vries I
Front Oncol. 2018; 8:562.
PMID: 30555799
PMC: 6281979.
DOI: 10.3389/fonc.2018.00562.
Recombinant Viruses for Cancer Therapy.
Chulpanova D, Solovyeva V, Kitaeva K, Dunham S, Khaiboullina S, Rizvanov A
Biomedicines. 2018; 6(4).
PMID: 30257488
PMC: 6316473.
DOI: 10.3390/biomedicines6040094.
Safety of Therapeutic Fever Induction in Cancer Patients Using Approved PAMP Drugs.
Reuter U, Oettmeier R, Hobohm U
Transl Oncol. 2018; 11(2):330-337.
PMID: 29425952
PMC: 5884214.
DOI: 10.1016/j.tranon.2018.01.019.
Hyperthermia exposure induces apoptosis and inhibits proliferation in HCT116 cells by upregulating miR-34a and causing transcriptional activation of p53.
Luo Z, Zheng K, Fan Q, Jiang X, Xiong D
Exp Ther Med. 2017; 14(6):5379-5386.
PMID: 29285066
PMC: 5740804.
DOI: 10.3892/etm.2017.5257.
Two is better than one: advances in pathogen-boosted immunotherapy and adoptive T-cell therapy.
Xin G, Schauder D, Zander R, Cui W
Immunotherapy. 2017; 9(10):837-849.
PMID: 28877635
PMC: 5941714.
DOI: 10.2217/imt-2017-0055.
Coley's Lessons Remembered: Augmenting Mistletoe Therapy.
Orange M, Reuter U, Hobohm U
Integr Cancer Ther. 2016; 15(4):502-511.
PMID: 27207233
PMC: 5739169.
DOI: 10.1177/1534735416649916.
In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth.
Bordonaro M, Shirasawa S, Lazarova D
Cancers (Basel). 2016; 8(5).
PMID: 27187477
PMC: 4880866.
DOI: 10.3390/cancers8050049.
Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery.
Lin I, Van T, Smooker P
Vaccines (Basel). 2015; 3(4):940-72.
PMID: 26569321
PMC: 4693226.
DOI: 10.3390/vaccines3040940.
Pseudomonas aeruginosa preparation plus chemotherapy for advanced non-small-cell lung cancer: a randomized, multicenter, double-blind phase III study.
Chang J, Liu Y, Han B, Zhou C, Bai C, Li J
Med Oncol. 2015; 32(5):139.
PMID: 25801231
DOI: 10.1007/s12032-015-0583-1.
Fever and the use of paracetamol during IL-2-based immunotherapy in metastatic melanoma.
Kostner A, Ellegaard M, Christensen I, Bastholt L, Schmidt H
Cancer Immunol Immunother. 2014; 64(3):349-55.
PMID: 25445814
PMC: 11029154.
DOI: 10.1007/s00262-014-1637-5.
Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy.
Maletzki C, Linnebacher M, Savai R, Hobohm U
Cancer Immunol Immunother. 2013; 62(8):1283-92.
PMID: 23832140
PMC: 11028761.
DOI: 10.1007/s00262-013-1455-1.